Faculty of Pharmacy, Université de Montréal, Montreal, Canada.
Research Centre, Centre Intégré Universitaire de santé et de services sociaux du Nord-de-l'île-de-Montréal, Montreal, Canada.
Curr Med Res Opin. 2022 Dec;38(12):2055-2067. doi: 10.1080/03007995.2022.2135835. Epub 2022 Nov 4.
e-MEDRESP is a novel web-based tool that provides easily interpretable information on patient adherence to asthma/chronic obstructive pulmonary disease (COPD) medications, using pharmacy claims data. This study investigated the feasibility of implementing e-MEDRESP in primary care.
In this 16-month prospective cohort study, e-MEDRESP was integrated into electronic medical records. Nineteen family physicians and 346 of their patients were enrolled. Counters embedded in the tool tracked physician use during the follow-up. Patient/physician satisfaction with e-MEDRESP was evaluated though telephone interviews and online questionnaires. The capacity of e-MEDRESP to improve adherence was explored using a pre-post analysis.
Overall, 245 patients had at least one medical visit during follow-up. e-MEDRESP was consulted by 15 (79%) physicians for 85 (35%) patients during clinic visits. Seventy-three patients participated in telephone interviews; 84% reported discussing their medication use with their physician; 33% viewed their e-MEDRESP report and indicated that it was easy to interpret. The physicians reported that the tool facilitated their evaluation of their patients' medication adherence (mean ± standard deviation rating: 4.8 ± 0.7, on a 5-point Likert scale). Although the pre-post analysis did not reveal improved adherence in the overall cohort, adherence improved significantly in patients whose adherence level was <80% and who were prescribed inhaled corticosteroids (26.9% [95% CI 14.3-39.3%]) or long-acting muscarinic agents (26.4% [95% CI 12.4-40.2%]).
e-MEDRESP was successfully integrated in clinical practice. It could serve as a useful tool to help physicians monitor their patients' medication adherence.
e-MEDRESP 是一种新型的基于网络的工具,它使用药房理赔数据提供易于解释的患者对哮喘/慢性阻塞性肺疾病(COPD)药物依从性的信息。本研究调查了在初级保健中实施 e-MEDRESP 的可行性。
在这项为期 16 个月的前瞻性队列研究中,e-MEDRESP 被整合到电子病历中。19 名家庭医生和他们的 346 名患者入组。嵌入工具中的计数器跟踪了随访期间医生的使用情况。通过电话访谈和在线问卷评估患者/医生对 e-MEDRESP 的满意度。通过前后分析探讨了 e-MEDRESP 改善依从性的能力。
总的来说,在随访期间,有 245 名患者至少有一次就诊。在就诊期间,15 名(79%)医生为 85 名(35%)患者咨询了 e-MEDRESP。73 名患者参加了电话访谈;84%的患者报告与医生讨论了他们的药物使用情况;33%的患者查看了他们的 e-MEDRESP 报告,并表示易于解释。医生报告说,该工具有助于他们评估患者的药物依从性(平均±标准偏差评分:4.8±0.7,5 分制 Likert 评分)。尽管前后分析并未显示总体队列中依从性的改善,但在依从性<80%且处方吸入皮质激素(26.9%[95%CI 14.3-39.3%])或长效毒蕈碱拮抗剂(26.4%[95%CI 12.4-40.2%])的患者中,依从性显著改善。
e-MEDRESP 已成功整合到临床实践中。它可以作为一种有用的工具,帮助医生监测患者的药物依从性。